Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
DEL PRIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership37,447 shares
Latest Disclosed Value $ 304,444
Bnp Paribas Arbitrage, Sa reports 365.18% increase in ownership of KUR / Kura Oncology, Inc.

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 37,447 shares of Kura Oncology, Inc. (DE:KUR) valued at $249,023 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 8,050 shares of Kura Oncology, Inc.. This represents a change in shares of 365.18% during the quarter. The current value of the position is $283,099 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Kura Oncology Equity 50127T109 37,447 29,397 365.18 304 266.27 0.0001
2026-02-10 2025-12-31 13F Kura Oncology Equity 50127T109 8,050 -10,150 -55.77 84 -48.45 0.0000
2025-11-13 2025-09-30 13F Kura Oncology Equity 50127T109 18,200 -217,028 -92.26 161 -88.14 0.0001
2025-08-14 2025-06-30 13F Kura Oncology Equity 50127T109 235,228 73,240 45.21 1,357 26.94 0.0008
2025-05-14 2025-03-31 13F Kura Oncology Equity 50127T109 161,988 -1,571 -0.96 1,069 -24.93 0.0006
2025-02-14 2024-12-31 13F Kura Oncology Equity 50127T109 163,559 148,272 969.92 1,425 377.85 0.0008
2024-11-13 2024-09-30 13F Kura Oncology Equity 50127T109 15,287 11,158 270.23 299 250.59 0.0002
2024-08-13 2024-06-30 13F Kura Oncology Equity 50127T109 4,129 -45,367 -91.66 85 -91.94 0.0001
2024-05-01 2024-03-31 13F Kura Oncology Equity 50127T109 49,496 -42,305 -46.08 1,056 -20.08 0.0009
2024-02-14 2023-12-31 13F/A-2 Kura Oncology Equity 50127T109 91,801 37,550 69.22 1,320 167.21 0.0015
2024-02-07 2023-12-31 13F/A-1 Kura Oncology Equity 50127T109 91,801 37,550 1,320 0.0002
2024-02-07 2023-12-31 13F Kura Oncology Equity 50127T109 91,801 37,550 1,320 0.0015
2023-11-14 2023-09-30 13F Kura Oncology Equity 50127T109 54,251 -4,680 -7.94 495 -20.71 0.0006
2023-08-09 2023-06-30 13F Kura Oncology Equity 50127T109 58,931 -55,494 -48.50 623 -55.47 0.0008
2023-05-12 2023-03-31 13F KURA ONCOLOGY EQUITY 50127T109 114,425 45,411 65.80 1,399 63.43 0.0020
2023-02-14 2022-12-31 13F Kura Oncology Equity 50127T109 69,014 -44,860 -39.39 856 -44.95 0.0013
2022-11-16 2022-09-30 13F/A-1 Kura Oncology Equity 50127T109 113,874 99,739 705.62 1,556 500.39 0.0025
2022-11-15 2022-09-30 13F Kura Oncology Equity 50127T109 113,874 99,739 1,556 0.0004
2022-08-12 2022-06-30 13F Kura Oncology Equity 50127T109 14,135 -14,461 -50.57 259 -43.57 0.0004
2022-05-18 2022-03-31 13F/A-1 Kura Oncology Equity 50127T109 28,596 -20,698 -41.99 460 -33.48 0.0006
2022-02-09 2021-12-31 13F KURA ONCOLOGY EQUITY 50127T109 49,294 -15,716 -24.17 690 -43.30 0.0010
2021-11-16 2021-09-30 13F/A-1 KURA ONCOLOGY EQUITY 50127T109 65,010 57,021 713.74 1,218 633.13 0.0017
2021-11-12 2021-09-30 13F KURA ONCOLOGY EQUITY 50127T109 12,529 4,540 384 0.0000
2021-08-10 2021-06-30 13F KURA ONCOLOGY EQUITY 50127T109 7,989 -88 -1.09 167 -27.19 0.0002
2021-05-07 2021-03-31 13F KURA ONCOLOGY EQUITY 50127T109 8,077 -62,036 -88.48 228 -90.04 0.0003
2021-02-10 2020-12-31 13F KURA ONCOLOGY EQUITY 50127T109 70,113 57,584 459.61 2,290 497.65 0.0043
2020-10-30 2020-09-30 13F KURA ONCOLOGY EQUITY 50127T109 12,529 8,531 213.38 384 489.23 0.0005
2020-08-06 2020-06-30 13F KURA ONCOLOGY EQUITY 50127T109 3,998 -10,194 -71.83 65 -53.90 0.0001
2020-05-13 2020-03-31 13F KURA ONCOLOGY EQUITY 50127T109 14,192 10,176 253.39 141 156.36 0.0003
2020-02-12 2019-12-31 13F KURA ONCOLOGY EQUITY 50127T109 4,016 -1,154 -22.32 55 -29.49 0.0001
2019-11-07 2019-09-30 13F KURA ONCOLOGY EQUITY 50127T109 5,170 2,036 64.96 78 27.87 0.0001
2019-07-30 2019-06-30 13F KURA ONCOLOGY EQUITY 50127T109 3,134 -2,747 -46.71 62 -37.11 0.0001
2019-04-25 2019-03-31 13F KURA ONCOLOGY EQUITY 50127T109 5,881 5,879 293,950.00 98 348,350.00 0.0002
2019-02-12 2018-12-31 13F KURA ONCOLOGY EQUITY 50127T109 2 -858 -99.77 0 -100.00 0.0000
2018-11-07 2018-09-30 13F KURA ONCOLOGY EQUITY 50127T109 860 0 0.00 15 0.00 0.0000
2018-07-25 2018-06-30 13F KURA ONCOLOGY EQUITY 50127T109 860 -4,120 -82.73 16 -83.87 0.0000
2018-05-11 2018-03-31 13F KURA ONCOLOGY EQUITY 50127T109 4,980 -80,422 -94.17 93 -92.88 0.0002
2018-03-05 2017-12-31 13F/A-1 KURA ONCOLOGY EQUITY 50127T109 85,402 84,010 6,035.20 1,307 6,430.00 0.0023
2018-02-01 2017-12-31 13F KURA ONCOLOGY EQUITY 50127T109 85,402 84,010 1,307
2017-11-03 2017-09-30 13F KURA ONCOLOGY STOCK 50127T109 1,392 -103 -6.89 21 53.85 0.0001
2017-08-03 2017-06-30 13F KURA ONCOLOGY STOCK 50127T109 1,495 1,495 14 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.